Sales & Marketing Sponsored Solution Spotlight: Enavia Launch Excellence Enavia Launch Excellence is transforming pharma launches with data-driven insights, seamless collaboration, and lifecycle optimisation.
Sales & Marketing Power launch excellence with generative AI As debate about the usefulness and ethics of generative artificial intelligence (AI) continues, the pharmaceutical industry needs to consider the advantages it can offer, especially for inc
Market Access Pharma’s post-pandemic launch performance problem: what’s th... The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.
Partner Content Partner Content How digital connectivity is driving faster patient access Sotiria Papanicolaou's take on digital innovation
Partner Content Partner Content Future focus: 3 tools for launching fast in the face of unce... Dan Twibell on navigating an accelerated launch
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.